▶ 調査レポート

バイオシミラー市場:世界及び中国市場分析・予測(~2024年)

• 英文タイトル:Biosimilars Market Insights 2019, Global and Chinese Analysis and Forecast to 2024

Prof Researchが調査・発行した産業分析レポートです。バイオシミラー市場:世界及び中国市場分析・予測(~2024年) / Biosimilars Market Insights 2019, Global and Chinese Analysis and Forecast to 2024 / C9OT0974資料のイメージです。• レポートコード:C9OT0974
• 出版社/出版日:Prof Research / 2019年10月1日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、143ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:Others
• 販売価格(消費税別)
  Single User¥444,000 (USD3,000)▷ お問い合わせ
  Site License¥562,400 (USD3,800)▷ お問い合わせ
  Global Site License¥740,000 (USD5,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「バイオシミラー市場:世界及び中国市場分析・予測(~2024年)」は、世界及び中国におけるバイオシミラー市場について調査・分析したレポートで、バイオシミラーの世界市場動向、市場規模、主要企業情報などが含まれています。バイオシミラーのタイプ別には、組換え非グリコシル化タンパク質(インスリン)に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。
・バイオシミラー産業の概要
・バイオシミラーの製造技術分析
・主要企業分析:企業概要、製品情報、連絡先など
・世界及び中国のバイオシミラー市場 2014年-2019年
・世界及び中国のバイオシミラー市場現状
・企業別分析:Sandoz International, Hospira, Teva Pharmaceutical, Dr. Reddy’s Laboratories, Biocon, Mylan, Amgen, Celltrion, Roche Diagnostics, Merck KGaAなど
・地域別分析:アメリカ、ヨーロッパ、日本、中国など
・タイプ別分析:組換え非グリコシル化タンパク質(インスリン)
・世界及び中国のバイオシミラー市場予測 2019年-2024年
・バイオシミラーの産業チェーン分析
・世界及び中国のマクロ経済動向と影響
・世界及び中国のバイオシミラー市場動向・課題・機会
・新規プロジェクトへの提言・結論

Biosimilars Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Biosimilars industry with a focus on the Chinese market. The report provides key statistics on the market status of the Biosimilars manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Biosimilars market covering all important parameters.

The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Biosimilars industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Biosimilars industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Biosimilars Industry before evaluating its feasibility.

There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.

For competitor segment, the report includes global key players of Biosimilars as well as some small players. At least 10 companies are included:
* Sandoz International
* Hospira
* Teva Pharmaceutical
* Dr. Reddy’s Laboratories
* Biocon
* Mylan
For complete companies list, please ask for sample pages.

The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share

For product type segment, this report listed main product type of Biosimilars market in gloabal and china.
* Recombinant Non-glycosylated Proteins (Insulin

For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Oncology
* Blood Disorders

Reasons to Purchase this Report:

* Estimates 2019-2024 Biosimilars market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

レポート目次

Chapter One Introduction of Biosimilars Industry
1.1 Brief Introduction of Biosimilars
1.2 Development of Biosimilars Industry
1.3 Status of Biosimilars Industry

Chapter Two Manufacturing Technology of Biosimilars
2.1 Development of Biosimilars Manufacturing Technology
2.2 Analysis of Biosimilars Manufacturing Technology
2.3 Trends of Biosimilars Manufacturing Technology

Chapter Three Analysis of Global Key Manufacturers
3.1 Sandoz International
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Hospira
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Teva Pharmaceutical
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Dr. Reddy’s Laboratories
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Biocon
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Mylan
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Amgen
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……

Chapter Four 2014-2019 Global and Chinese Market of Biosimilars
4.1 2014-2019 Global Capacity, Production and Production Value of Biosimilars Industry
4.2 2014-2019 Global Cost and Profit of Biosimilars Industry
4.3 Market Comparison of Global and Chinese Biosimilars Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Biosimilars
4.5 2014-2019 Chinese Import and Export of Biosimilars

Chapter Five Market Status of Biosimilars Industry
5.1 Market Competition of Biosimilars Industry by Company
5.2 Market Competition of Biosimilars Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Biosimilars Consumption by Application/Type

Chapter Six 2019-2024 Market Forecast of Global and Chinese Biosimilars Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Biosimilars
6.2 2019-2024 Biosimilars Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Biosimilars
6.4 2019-2024 Global and Chinese Supply and Consumption of Biosimilars
6.5 2019-2024 Chinese Import and Export of Biosimilars

Chapter Seven Analysis of Biosimilars Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry

Chapter Eight Global and Chinese Economic Impact on Biosimilars Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Biosimilars Industry

Chapter Nine Market Dynamics of Biosimilars Industry
9.1 Biosimilars Industry News
9.2 Biosimilars Industry Development Challenges
9.3 Biosimilars Industry Development Opportunities

Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment

Chapter Eleven Research Conclusions of Global and Chinese Biosimilars Industry

Tables and Figures
Figure Biosimilars Product Picture
Table Development of Biosimilars Manufacturing Technology
Figure Manufacturing Process of Biosimilars
Table Trends of Biosimilars Manufacturing Technology
Figure Biosimilars Product and Specifications
Table 2014-2019 Biosimilars Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilars Capacity Production and Growth Rate
Figure 2014-2019 Biosimilars Production Global Market Share
Figure Biosimilars Product and Specifications
Table 2014-2019 Biosimilars Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilars Capacity Production and Growth Rate
Figure 2014-2019 Biosimilars Production Global Market Share
Figure Biosimilars Product and Specifications
Table 2014-2019 Biosimilars Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Biosimilars Capacity Production and Growth Rate
Figure 2014-2019 Biosimilars Production Global Market Share
Figure Biosimilars Product and Specifications
Table 2014-2019 Biosimilars Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilars Capacity Production and Growth Rate
Figure 2014-2019 Biosimilars Production Global Market Share
Figure Biosimilars Product and Specifications
Table 2014-2019 Biosimilars Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Biosimilars Capacity Production and Growth Rate
Figure 2014-2019 Biosimilars Production Global Market Share
Figure Biosimilars Product and Specifications
Table 2014-2019 Biosimilars Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilars Capacity Production and Growth Rate
Figure 2014-2019 Biosimilars Production Global Market Share
Figure Biosimilars Product and Specifications
Table 2014-2019 Biosimilars Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilars Capacity Production and Growth Rate
Figure 2014-2019 Biosimilars Production Global Market Share
Figure Biosimilars Product and Specifications
Table 2014-2019 Biosimilars Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Biosimilars Capacity Production and Growth Rate
Figure 2014-2019 Biosimilars Production Global Market Share
……
……
Table 2014-2019 Global Biosimilars Capacity List
Table 2014-2019 Global Biosimilars Key Manufacturers Capacity Share List
Figure 2014-2019 Global Biosimilars Manufacturers Capacity Share
Table 2014-2019 Global Biosimilars Key Manufacturers Production List
Table 2014-2019 Global Biosimilars Key Manufacturers Production Share List
Figure 2014-2019 Global Biosimilars Manufacturers Production Share
Figure 2014-2019 Global Biosimilars Capacity Production and Growth Rate
Table 2014-2019 Global Biosimilars Key Manufacturers Production Value List
Figure 2014-2019 Global Biosimilars Production Value and Growth Rate
Table 2014-2019 Global Biosimilars Key Manufacturers Production Value Share List
Figure 2014-2019 Global Biosimilars Manufacturers Production Value Share
Table 2014-2019 Global Biosimilars Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Biosimilars Production
Table 2014-2019 Global Supply and Consumption of Biosimilars
Table 2014-2019 Import and Export of Biosimilars
Figure 2018 Global Biosimilars Key Manufacturers Capacity Market Share
Figure 2018 Global Biosimilars Key Manufacturers Production Market Share
Figure 2018 Global Biosimilars Key Manufacturers Production Value Market Share
Table 2014-2019 Global Biosimilars Key Countries Capacity List
Figure 2014-2019 Global Biosimilars Key Countries Capacity
Table 2014-2019 Global Biosimilars Key Countries Capacity Share List
Figure 2014-2019 Global Biosimilars Key Countries Capacity Share
Table 2014-2019 Global Biosimilars Key Countries Production List
Figure 2014-2019 Global Biosimilars Key Countries Production
Table 2014-2019 Global Biosimilars Key Countries Production Share List
Figure 2014-2019 Global Biosimilars Key Countries Production Share
Table 2014-2019 Global Biosimilars Key Countries Consumption Volume List
Figure 2014-2019 Global Biosimilars Key Countries Consumption Volume
Table 2014-2019 Global Biosimilars Key Countries Consumption Volume Share List
Figure 2014-2019 Global Biosimilars Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Biosimilars Consumption Volume Market by Application
Table 89 2014-2019 Global Biosimilars Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Biosimilars Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Biosimilars Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Biosimilars Consumption Volume Market by Application
Figure 2019-2024 Global Biosimilars Capacity Production and Growth Rate
Figure 2019-2024 Global Biosimilars Production Value and Growth Rate
Table 2019-2024 Global Biosimilars Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Biosimilars Production
Table 2019-2024 Global Supply and Consumption of Biosimilars
Table 2019-2024 Import and Export of Biosimilars
Figure Industry Chain Structure of Biosimilars Industry
Figure Production Cost Analysis of Biosimilars
Figure Downstream Analysis of Biosimilars
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Biosimilars Industry
Table Biosimilars Industry Development Challenges
Table Biosimilars Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Biosimilarss Project Feasibility Study